 | Up a level |
Kanis, J A; Johansson, H; McCloskey, E V; Liu, E; Åkesson, K E; Anderson, F A; Azagra, R; Bager, C L; Beaudart, C; Bischoff-Ferrari, H A; Biver, E; Bruyère, O; Cauley, J A; Center, J R; Chapurlat, R; Christiansen, C; Cooper, C; Crandall, C J; Cummings, S R; da Silva, J A P; ... (2023). Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX. Osteoporosis international, 34(12), pp. 2027-2045. Springer-Verlag 10.1007/s00198-023-06870-z
Vandenput, L; Johansson, H; McCloskey, E V; Liu, E; Åkesson, K E; Anderson, F A; Azagra, R; Bager, C L; Beaudart, C; Bischoff-Ferrari, H A; Biver, E; Bruyère, O; Cauley, J A; Center, J R; Chapurlat, R; Christiansen, C; Cooper, C; Crandall, C J; Cummings, S R; da Silva, J A P; ... (2022). Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan. Osteoporosis international, 33(10), pp. 2103-2136. Springer-Verlag 10.1007/s00198-022-06435-6
Biver, E; Calmy, A; Aubry-Rozier, B; Birkhäuser, M; Bischoff-Ferrari, H A; Ferrari, S; Frey, D; Kressig, R W; Lamy, O; Lippuner, Kurt; Suhm, N; Meier, C (2019). Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis. Osteoporosis international, 30(5), pp. 1125-1135. Springer-Verlag 10.1007/s00198-018-4794-0
Longhi, A; Bielack, S S; Grimer, R; Whelan, J; Windhager, R; Leithner, A; Gronchi, A; Biau, D; Jutte, P; Krieg, A H; Klenke, Frank M.; Grignani, G; Donati, D M; Capanna, R; Casanova, J; Gerrand, C; Bisogno, G; Hecker-Nolting, S; De Lisa, M; D'Ambrosio, L; ... (2017). Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients. European journal of cancer, 74, pp. 9-16. Elsevier 10.1016/j.ejca.2016.12.016
Ferrari, S; Adachi, J D; Lippuner, Kurt; Zapalowski, C; Miller, P D; Reginster, J-Y; Törring, O; Kendler, D L; Daizadeh, N S; Wang, A; O'Malley, C D; Wagman, R B; Libanati, C; Lewiecki, E M (2015). Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years. Osteoporosis international, 26(12), pp. 2763-2771. Springer 10.1007/s00198-015-3179-x
Ferrari, S; Mudde, G C; Rieger, M; Veyradier, A; Kremer Hovinga, J A; Scheiflinger, F (2009). IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura. Journal of thrombosis and haemostasis, 7(10), pp. 1703-10. Oxford: Wiley-Blackwell 10.1111/j.1538-7836.2009.03568.x
Tripodi, A; Peyvandi, F; Chantarangkul, V; Palla, R; Afrasiabi, A; Canciani, M T; Chung, D W; Ferrari, S; Fujimura, Y; Karimi, M; Kokame, K; Kremer Hovinga, J A; Lämmle, B; de Meyer, S F; Plaimauer, B; Vanhoorelbeke, K; Varadi, K; Mannucci, P M (2008). Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13). Journal of thrombosis and haemostasis, 6(9), pp. 1534-41. Oxford: Blackwell 10.1111/j.1538-7836.2008.03099.x
Lippuner, K; Ferrari, S (2008). Osteoporosetherapie mit Teriparatid. Hausarztpraxis - Fortschritte der Medizin, 2008(14) Zürich: Prime Public Media AG
Lippuner, K; Ferrari, S (2008). Traitement de l'ostéoporose par le tériparatide. Gériatrie pratique, 2008(14) Basel: Medien & Medizin Verlag MMV AG
